Related Experiment Videos
Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism
J Gogusev1, P Duchambon, B Hory
1INSERM Unité 90, Hôpital Necker, Paris, France.
Abstract:
The factors involved in abnormal parathyroid cell secretory function and growth in patients with primary (I degree) and secondary (II degree) hyperparathyroidism are still incompletely understood. We compared the expression of the calcium-sensing receptor (CaR) at the gene message and the protein level in parathyroid tissue obtained from patients with I degree non-uremic or II degree uremic hyperparathyroidism with that in normal parathyroid tissue, using in situ hybridization and immunohistochemistry techniques. The expression of the CaR mRNA and protein was reduced in most cases of I degree adenoma and II degree hyperplasia, compared with strong expression normal parathyroid tissue. In II degree hyperparathyroidism, expression of both receptor mRNA message and protein was often particularly depressed in nodular areas, compared with adjacent non-nodular hyperplasia. Decreased Ca-R expression in adenomatous and hyperplastic parathyroid glands would be compatible with a less efficient control of PTH synthesis and secretion by plasma calcium than in normal parathyroid tissue.
Insights
Parathyroid glands in primary and secondary hyperparathyroidism show reduced calcium-sensing receptor (CaR) expression. This decrease in CaR mRNA and protein impacts parathyroid cell function and growth, suggesting less efficient calcium control.
Area of Science:
- Endocrinology
- Molecular Biology
- Nephrology
Background:
- Abnormal parathyroid cell secretory function and growth in hyperparathyroidism are not fully understood.
- The calcium-sensing receptor (CaR) plays a crucial role in regulating parathyroid hormone (PTH) secretion.
- Primary and secondary hyperparathyroidism involve distinct pathophysiological mechanisms.
Purpose of the Study:
- To compare CaR gene and protein expression in normal, primary, and secondary hyperparathyroid parathyroid tissues.
- To investigate the role of CaR in parathyroid hyperplasia and adenoma development.
- To elucidate the relationship between CaR expression and parathyroid cell function in hyperparathyroidism.
Main Methods:
- In situ hybridization was used to assess CaR mRNA levels.
- Immunohistochemistry was employed to evaluate CaR protein expression.
- Parathyroid tissues from patients with primary (non-uremic) and secondary (uremic) hyperparathyroidism were analyzed.
Main Results:
- CaR mRNA and protein expression were reduced in most primary adenomas and secondary hyperplasias compared to normal parathyroid tissue.
- In secondary hyperparathyroidism, CaR expression was notably lower in nodular hyperplastic areas than in non-nodular regions.
- Reduced CaR expression was observed in both adenomatous and hyperplastic glands.
Conclusions:
- Decreased CaR expression in hyperparathyroid glands suggests impaired regulation of PTH synthesis and secretion by plasma calcium.
- Reduced CaR levels may contribute to the abnormal growth and secretory function of parathyroid cells in hyperparathyroidism.
- These findings highlight the importance of CaR in the pathogenesis of hyperparathyroidism.